Wedge Capital Management L L P NC Buys 71,349 Shares of Bath & Body Works, Inc. $BBWI

Wedge Capital Management L L P NC grew its position in Bath & Body Works, Inc. (NYSE:BBWI) by 49.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 214,362 shares of the company’s stock after acquiring an additional 71,349 shares during the quarter. Wedge Capital Management L L P NC owned 0.10% of Bath & Body Works worth $4,304,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Alliancebernstein L.P. boosted its holdings in Bath & Body Works by 2.2% during the 3rd quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after acquiring an additional 123,648 shares during the period. Cooper Creek Partners Management LLC boosted its stake in shares of Bath & Body Works by 42.7% during the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after acquiring an additional 4,949,796 shares during the period. AQR Capital Management LLC raised its holdings in Bath & Body Works by 17.1% in the third quarter. AQR Capital Management LLC now owns 4,921,968 shares of the company’s stock worth $126,790,000 after purchasing an additional 718,642 shares in the last quarter. Finally, GMT Capital Corp raised its stake in shares of Bath & Body Works by 8.8% during the 2nd quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock worth $121,847,000 after acquiring an additional 329,300 shares in the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on BBWI. Barclays lifted their price objective on shares of Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Monday, March 2nd. Jefferies Financial Group began coverage on shares of Bath & Body Works in a report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price objective for the company. Telsey Advisory Group raised their price objective on Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a report on Thursday, March 5th. Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. Finally, Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and upped their target price for the stock from $21.00 to $25.00 in a research note on Tuesday, February 17th. Three investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works has a consensus rating of “Hold” and a consensus target price of $24.00.

Bath & Body Works Trading Up 0.1%

NYSE BBWI opened at $16.81 on Monday. The stock has a fifty day simple moving average of $21.65 and a 200-day simple moving average of $22.31. The stock has a market cap of $3.38 billion, a PE ratio of 5.34, a P/E/G ratio of 1.68 and a beta of 1.48. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $34.66.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.28. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. During the same period in the previous year, the firm earned $2.09 EPS. Bath & Body Works’s revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.8%. Bath & Body Works’s dividend payout ratio (DPR) is presently 25.40%.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.